
|
Report Date : |
27th March, 2006 |
|
Name : |
D.
K. ENTERPRISES |
|
|
|
|
Registered Office : |
41,
Raghunayakulu Street, Chennai – 600 003, Tamilnadu, India |
|
|
|
|
Date of Incorporation : |
2002 |
|
|
|
|
IEC No.: |
0402001630 |
|
|
|
|
TAN No.: (Tax Deduction &
Collection Account No.) |
-- |
|
|
|
|
PAN No.: (Permanent Account No.) |
-- |
|
|
|
|
Legal Form : |
Partnership
concern with an unlimited liability of the partners. |
|
|
|
|
Line of Business : |
Importer
and Trader of Bulk Drugs, Chemicals and Pharmaceuticals. |
|
MIRA’s Rating : |
Ba |
RATING
|
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is
considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 150000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject
is a well – established Proprietory concern engaged in the business as
importers and traders of bulk drugs, Chemicals and pharmaceuticals. Trade
relations are fair. The concern is doing very well. Its payments are correct
and as per commitments. The
concern can be considered good for normal business dealings at usual trade
terms and conditions. |
|
Registered Office : |
41,
Raghunayakulu Street, Chennai – 600 003, Tamilnadu, India |
|
Tel. No.: |
91-
44- 25352767 / 25355801 / 25357534 / 25353519 |
|
Fax No.: |
91-
44- 25350234 / 25353543 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned
|
|
|
|
|
Warehouse: |
166 GNT Road, Mathaearam, Chennai, Tamilnadu,
India |
|
Built up Area : |
30000
Sq. ft |
|
Location : |
Owned
|
|
|
|
|
Branches : |
3rd
Floor, Samaj Deep Building, Near Saraswat Bank, Mumbai – 400067 |
|
|
|
|
Branches : |
16,
Nyniappa Street, Chennai – 600 003, Tamilnadu, India. |
|
Tel. No.: |
91- 44- 25358434 / 25357624 |
|
Fax No.: |
91- 44- 25358436 |
|
Name : |
Mr.
K. Ramlal Jain |
|
Designation : |
Partner |
|
Address : |
41,
Raghunayakulu Street, Chennai – 600 003 |
|
Date of Birth/Age : |
42
Years |
|
Qualification : |
S.
S. C. |
|
|
|
|
Name : |
Mr.
K. Vijaylal Jain |
|
Designation : |
Partner
|
|
Address : |
208,
Mirt Street, Chennai - 600003 |
|
Date of Birth/Age : |
5
Years |
|
Qualification : |
S.
S. L. C. |
|
|
|
|
Name : |
Mr.
K Parasmal Jain |
|
Designation : |
Partner
|
|
Address : |
41,
Raghunayakulu Street, Chennai – 600 003 |
|
Qualification : |
B
Com. |
|
|
|
|
Name : |
Mr.
K Ramlal Jain |
|
Designation : |
Partner
|
|
Address : |
27,
Raghunayakulu Street, Chennai – 600 003 |
|
Date of Birth/Age : |
43
years |
|
Qualification : |
S.S.L.C.
|
|
|
|
|
Line of Business : |
Importer
and Trader of Bulk Drugs, Chemicals and Pharmaceuticals. |
|
|
|
|
Products : |
v Pharmatose Lactose (Different
grades) v Primojil, Primellose,
Prejal Pa 5 Ph v Kollidon (All Grades) v Cremphor, Lutrol (All
Grades) v Asparame /
L-Phenylalanine v Xanthan Gum v Mannitol (Direct
Compressible Grades) v Hydroxy Propyl Methyl
Cellulose and Ethyl Cellulose i.e. 10 different cellulose of 180
specifications v Betacyclo Dextrine v Alphalipoic Acid 99.50% v Furazolidone Inositol
Sucralfate Pirectam v
Calcium Citrate USP24 v
Prejel Pa 5pH- Pregelatinised Startch v
Primellose Croscarmellose sodium v
Primojel Sodium Starch Glycolate |
|
|
|
|
Imports from : |
The Netherlands, USA, Germany, China, France,
Taiwan |
|
|
|
|
Terms : |
|
|
Selling : |
Cash or Credit (90 days) terms. |
|
|
|
|
Purchasing : |
L/C
or Credit (90 days) terms. |
|
Customers : |
v
Sun Pharmaceutical Industries Limited, 10 Jeypore Nagar, Chennai – 600 086, Tamilnadu Te1ephone Number – 91-44-28259017 / 28267815 v
Micro Labs Limited, 423 Kilpauk Garden Street, Chennai – 600 010,
Tamilnadu v
Torrent Pharmaceuticals Limited 560/562 Anna Salai, Chennai – 600 018 Telephone Number – 91- 44- 24349302 / 24342062 v
Ranbaxy Laboratories Limited 137/1 Anna Salai, Chennai – 600 015, Tamilnadu Telephone Number – 91- 44- 22351194 / 22353448 v
Cadila Pharmaceuticals Limited 23-A/2, North Boag Road, Chennai – 600 017,
Tamilnadu Telephone Number – 91-
44- 28222842 / 28282499 v
Sarabhai Chemicals, 3 Montieth Lane, Egmore, Chennai – 600 008,
Tamilnadu v
Zydus Cadila Health Care Limited 98th Street, Dr. Subburayan Nagar,
Chennai – 600 024, Tamilnadu Telephone Number – 91- 44- 24817465 / 24817478 v
Hetero Drugs Limited, Andhra Pradesh v
Lee Pharma Limited, Andhra Pradesh v
Dr. Reddy’a Laboratories Limited, Andhra Pradesh v
Biological E Limited, Andhra Pradesh v
Granules India Limited, Andhra Pradesh v
Aurabindo Pharma Limited, Andhra Pradesh v
Zen Biotech, Andhra Pradesh v
UNI-Sankyo Limited, Andhra Pradesh v
Polaris Health Care Limited, Andhra Pradesh v
Sri Krishna Pharma, Andhra Pradesh v
Micro Labs Limited & its’ Group, Karnataka v
The Himalaya Drug Company, Karnataka v
Strides Arcolab Limited, Karnataka v
Astra Zeneca Pharma Limited, Karnataka v
Glaxo-SmithKline India Private Limited, Karnataka v
Ishaan Labs Private Limited, Karnataka v
BPRL Limited, Karnataka v
Remidex Pharma, Karnataka v
Bal Pharma Limited, Karnataka v
Tetragaon Chemie, Karnataka v
Global Calcium Limited, Karnataka v
Anglo French & Drugs, Karnataka v
Karnataka Antibiotics Pharmaceuticals Limited, Karnataka v
Medopharm, Tamilnadu v
Tablets India Limited, Tamilnadu v
Apex Laboratories Private Limited, Tamilnadu v
The Madras Pharmaceuticals Limited, Tamilnadu v
Citadel & Aurobindo Pharma Limited, Tamilnadu v
Fourts India Private Limited, Tamilnadu v
Spic Limited, Tamilnadu v
Sai Mirra Innopharma Private Limited, Tamilnadu v
Dr. Reddy’s Laboratories Limited (Group), Tamilnadu v
Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh v
Lark Laboratories v
Dabur India Limited, Delhi v
Dabur Indai Limited, Kolkata, West Bengal v
Dabur India Limited, Nepal v
Welcure Drugs & Pharma v
Promed Exports v
Wings Pharma v
Nestos Pharma, Delhi v
Nestos Phrama, Goa v
Nestos Pharma, Ghaziabad, Uttar Pradesh |
|
|
|
|
No. of Employees : |
33 |
|
|
|
|
Bankers : |
v Union Bank of India,
Sowcarpet Branch, Mint Street, Chennai – 600 003, Tamilnadu. v
Standard Chartered Bank, Rajaji Sala, Chennai |
|
|
|
|
Facilities : |
The concern do not enjoy facility from its
bankers |
|
|
|
|
Banking Relations : |
Satisfactory
|
|
|
|
|
Auditors : |
Mr.
Rajendra Kumar Chartered
Accountant |
|
Address: |
374,
Mint Street, Chennai – 600 003 |
|
Tel. No.: |
91-41-25354874 |
|
|
|
|
Associates/Subsidiaries
: |
v
Kawarlal & Company –Parent Firm 27, Raghunayakulu Street, Chennai – 600 003,
Tamilnadu. Line of business: Importers of chemical exciepients of pharmaceuticals v
Kawarlal & Sons 27, Raghunayakulu Street, Chennai – 600 003,
Tamilnadu. Line of business: Importers of chemical
exciepients of pharmaceuticals |
|
Capital Investment : |
|
|
Owned : |
Rs.
0.103 Millions |
|
Borrowed : |
- |
|
Total : |
Rs.
0.103 Millions |
FINANCIAL
DATA
[all figures are in Rupees Millions]
|
SOURCES OF FUNDS |
|
31.03.2005 |
31.03.2004 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
0.103 |
(0.405) |
|
|
2] Share Application Money |
|
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
|
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
|
0.000 |
0.000 |
|
NETWORTH
|
|
0.104 |
(0.405) |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
0.000 |
0.000 |
|
|
2] Unsecured Loans |
|
42.988 |
26.227 |
|
TOTAL
BORROWING
|
|
42.988 |
26.227 |
|
|
DEFERRED TAX LIABILITIES |
|
|
|
|
|
|
|
|
|
|
TOTAL
|
|
43.092 |
25.822 |
|
|
|
|
|
|
|
APPLICATION OF FUNDS
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block]
|
|
0.595 |
0.000 |
|
Capital work-in-progress
|
|
0.000 |
0.000 |
|
|
|
|
|
|
|
INVESTMENT
|
|
0.000 |
0.000 |
|
DEFERREX TAX ASSETS
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES
|
|
|
|
|
|
|
Inventories
|
|
19.048 |
18.427 |
|
|
Sundry Debtors
|
|
37.220 |
11.649 |
|
|
Cash & Bank Balances
|
|
1.367 |
0.327 |
|
|
Other Current Assets
|
|
1.585 |
0.005 |
|
|
Loans & Advances
|
|
1.805 |
0.007 |
Total Current Assets
|
|
61.025 |
30.415 |
|
Less : CURRENT LIABILITIES & PROVISIONS
|
|
|
|
|
|
|
Current Liabilities & Provision
|
|
18.528 |
4.593 |
|
|
Provisions
|
|
|
|
Total Current Liabilities
|
|
18.528 |
4.593 |
|
Net Current
Assets
|
|
42.497 |
25.822 |
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES
|
|
0.000 |
0.000 |
|
|
|
|
|
|
|
TOTAL
|
|
43.092 |
25.822 |
|
|
PARTICULARS |
31.03.2005 |
31.03.2004 |
31.03.2003 |
Sales Turnover [including other income]
|
139.616 |
39.392 |
1.549 |
|
|
|
|
|
Profit/(Loss) Before Tax
|
1.025 |
0.510 |
0.130 |
Provision for Taxation
|
0.000 |
0.000 |
0.000 |
Profit/(Loss) After Tax
|
1.025 |
0.510 |
0.130 |
|
|
|
|
|
Total Expenditure
|
137.512 |
4.763 |
0.452 |
|
PARTICULARS |
|
31.03.2005 |
31.03.2004 |
31.03.2003 |
PAT / Total Income
|
(%)
|
0.73
|
1.29 |
8.39 |
|
|
|
|
|
|
Net Profit Margin
(PBT/Sales) |
(%) |
0.73
|
1.29 |
8.39 |
|
|
|
|
|
|
Return on Total Assets
(PBT/Total Assets} |
(%) |
1.66
|
1.67 |
- |
|
|
|
|
|
|
Return on Investment (ROI)
(PBT/Networth) |
|
9.95
|
(1.25) |
- |
|
|
|
|
|
|
Debt Equity Ratio
(Total Liability/Networth) |
|
591.50
|
(76.09) |
- |
|
|
|
|
|
|
Current Ratio
(Current Asset/Current
Liability) |
|
3.29
|
6.62 |
- |
Subject
imports the following excipients:
Name of the Company
|
Country
|
Product
|
|
DMV
International |
The
Netherlands |
Pharmatose
Lactose (Different grades) |
|
|
|
Primojil,
Primellose, Prejal Pa 5 Ph |
|
BASF |
USA |
Kollidon
(All Grades) |
|
|
Germany |
Cremphor,
Lutrol (All Grades) |
|
The
NutraSweet Co |
USA |
Asparame
/ L-Phenylalanine |
|
Archer
Daniels Midland Company |
USA |
Xanthan
Gum |
|
SPI
Polyols |
France |
Mannitol
(Direct Compressible Grades) |
|
Taian
Ruitai Cellulose Co. Limited |
China |
Hydroxy
Propyl Methyl Cellulose and Ethyl Cellulose i.e. 10 different cellulose of
180 specifications |
|
Jiangsu
Guo tAi Intl. Group Huatai Imp. and Export Co. Limited |
China |
Betacyclo
Dextrine |
|
Nanjing
Textiles Imp / Exp. Corpn. Limited |
China |
Alphalipoic
Acid 99.50% |
|
|
|
Furazolidone
Inositol Sucralfate Pirectam |
|
China
National Chemical Construction Dalian Co |
China |
Calcium
Citrate USP24 |
|
Nanhane
Industrial Company |
China |
-- |
|
Weiming
Pharmaceutical Company |
Taiwan |
-- |
|
Deosen
Corporation |
China |
-- |
|
Nanang
Indl Company |
China
|
|
List
of products in which the concern deals is given below:
·
Lactose
USP 23/NF 18, Ph. Eur.III, BP93, JP XIII, Pharmatose 200 Mesh, HMS, DMV
International, Holland
·
Lactose
USP 23/NF 18, Ph. Eur.III, BP93, JP XIII, Pharmatose DCL15, HMS, DMV
International, Holland
·
Cbosil
– M5 – Fumed Silica / Coloidol, Silicon Director-oxide-
Manufactured By M/s. Cabot. Sanmar
Limited, Mettur Dam
·
P.V.P.K.
– 30- Origin: Chinese K –90, CI Grade
·
HPMC
USP HM E5 E15, K4m, K15m, K100 manufacture
·
Ethyl
Cellulose N7 & N20 Origin: China, -Manufactured By Nianjiani, China
·
Xanthan
Gum Brand Keltrol T (Pharma Grade),- Manufactured By Kelco, U.K. ( Monsanto,
U.S.A. Group Company)
·
Xanthan
Gum Brand Keltrol in various Grades according to applications (Authorised
Distributor of Monsanto Group)
·
Aspartame
Powder USP 23, Brand Nutrasweet – Monsanto, U.S.A. ( Research Product of
Monsanto,- Authorised Distributor of Monsanto Group)
·
Carbopol
934, 940 – B.F. Goodrich, U.S.A.
·
Sodium
Starch Glycolate USP/ NF – Brand Primeojel
·
Croscarmellose
Sodium USP /NF – Brand Primellose, (Equivalent Ac Disol)
·
Pregelatinised
starch – Brand Prejel Pa 5 PH
·
Mannitol
Pyrogen free – USP23, BP93 Origin : China
M/s. DMV International – Holland, US FDA
Equivalent and DMF Producer (Largest) of pharmaceutical and Direct Compressible
Lactose grade globally - We, as Largest Distributor in India.
|
BRAND |
PRODUCT |
PACKING |
|
Pharmatose |
Lactose 200 Mesh IP, BP, Ph.Eur,
USP/NF, JP |
25kg. Bag |
|
Pharmatose |
Lactose 50/80/125/150/450 Mesh IP, BP,
Ph.Eur, USP/NF, JP |
25kg. Bag |
|
HMS |
Lactose 200 Mesh IP, BP, Ph.Eur,
USP/NF, JP |
25kg. Bag |
|
Pharmatose |
DCL 11 Spray Dried Lactose IP, BP,
Ph.Eur, USP/NF, JP |
40kg. P.Drum |
|
Pharmatose |
DCL 15 Monohydrate Lactose IP, BP,
Ph.Eur, USP/NF, JP |
25kg. Bag |
|
Pharmatose |
DCL 21 Anhydrous Lactose IP, BP,
Ph.Eur, USP/NF, JP |
50kg. Drum |
|
Primojel |
Sodium Starch Glycolate IP, BP, Ph.Eur,
USP/NF, JP |
50kg. Drum |
|
Primellose |
Croscarmellose Sodium IP, BP, Ph.Eur,
USP/NF, JP |
25kg. Drum |
|
Prejel Pa 5 pH |
Pregelatinised Starch IP, BP, Ph.Eur,
USP/NF, JP |
25kg. Bag |
|
|
|
|
M/s. Taian Ruitai Cellulose Co. Ltd. – China, World’s IIIrd and Asia’s IInd producer of Cellulose
Ether and its derivatives - We, as Exclusive Distributor for India
|
BRAND |
PRODUCT |
PACKING |
|
Rutocel |
HPMC 60 RT 5CPS Premium IP, BP, USP 26,
JP |
25kg.F. Drum* |
|
Rutocel |
HPMC 60RT 15CPS IP, BP, USP 26, JP |
25kg. F. Drum* |
|
Rutocel |
HPMC 60 RT 50CPS IP, BP, USP 26, JP |
25kg. F. Drum* |
|
Rutocel |
HPMC 75 RT K4M/K15M/K100M IP, BP, USP
26, JP |
25kg. F. Drum* |
|
Fetocel |
Ethyl Cellulose N7/N10/N20/N50 IP, BP,
USP 26, JP |
25kg. F. Drum* |
|
Coatcel |
Hydroxy Propyl Cellulose RT-LF IP, BP,
USP 26, JP |
25kg. F. Drum* |
· Multi colour, Tamper proof Seal Fibre Drum
M/s. Amtex – Quimica, World’s second Largest dedicated Producer of Sodium
Carboxy Methyl Cellulose (32000 MT) - We, as Exclusive Distributor for India
|
BRAND |
PRODUCT |
PACKING |
|
Kemsel |
Sodium CMC 99.5% Purity |
|
Sodium CMC – Different Custom made Viscosity, D. S., Particle size, etc. can
offer on requests.
CMC – CarboxyMethylCellulose
M/s. BASF – USA/Germany - 150 years old, world’s No. 1 technology based
producer
We, as Authorized Distributor in India
|
BRAND |
PRODUCT |
PACKING |
|
Kollidon |
K30 PVP K30 IP, BP, Ph.Eur, USP/NF, JP |
50kg. Drum |
|
Kollidon |
K90 PVP K90 IP, BP, Ph.Eur, USP/NF, JP |
25kg. Carton |
|
Kollidon |
CL Cross Linked PVP IP, BP, Ph.Eur,
USP/NF, JP |
40kg. Drum |
|
Kollidon |
VA64 IP, BP, Ph.Eur, USP/NF, JP |
35kg. Drum |
|
Kollicoat |
MAE 100 P (=Eudragit L 100-55) IP, BP,
Ph.Eur, USP/NF, JP |
25kg. Cartoon |
|
Kollicoat |
MAE 30 P (=Eudragit L 30D) IP, BP,
Ph.Eur, USP/NF, JP |
25kg. Carbouy |
|
Cremophor |
Cremophor RH 40/60/EL IP, BP, Ph.Eur,
USP/NF, JP |
60kg. Drum |
|
Lutrol |
Lutrol F 127 / F68 IP, BP, Ph.Eur,
USP/NF, JP |
90kg. Drum |
PVP – Polyvinyl Pyrollidone
M/s. Bolak Co. Ltd. - Korea
|
BRAND |
PRODUCT |
PACKING |
|
Bolak |
Ca-CMC USP/BP |
10kg. Tin |
Ca-CMC – Calcium CarboxyMethylCellulose
M/s. SPI Polyols – USA/France
|
BRAND |
PRODUCT |
PACKING |
|
Mannogem |
Mannitol Powder USP/BP |
72.6kg Drum |
M/s. The NutraSweet Company – USA
- Sweetener is sold in more than 100 countries and used in over 5,000 products.
|
BRAND |
PRODUCT |
PACKING |
|
NutraSweet |
Aspartame Powder USP 26/NF |
1/25kg Drum |
|
NutraSweet |
L-Phenylalanine |
25kg. Drum |
|
NutraSweet |
Neotame (8000 x Sugar) IP |
250gms. P. container |
M/s. Saputo Cheese g.p., Canada - We as Distributor for India
|
BRAND |
PRODUCT |
PACKING |
|
Lactose |
Lactose mesh 200 IP |
25kg. Bag |
M/s. Changshu Wanxing - China
|
BRAND |
PRODUCT |
PACKING |
|
ALA |
Alpha Lipoic Acid |
10/25kg. Drum |
M/s. Cabot Sanmar Ltd. – India – We are Authorized Distributor for T.N., Karnataka,
Kerala.
|
BRAND |
PRODUCT |
PACKING |
|
Cab-O-Sil |
Cab-O-Sil M5 |
5kg. Bag |
M/s. Nanhang Industrial Co., Ltd.
|
BRAND |
PRODUCT |
PACKING |
|
Povidone |
PVP K 30 |
25kg. F. Drum |
M/s. Nantong Feiyu Fine Chemicals Co., Ltd. – China
|
BRAND |
PRODUCT |
PACKING |
|
Calcium Ca |
Calcium Citrate USP 25/26 |
25kg F. Drum |
M/s. Shandong Deosen Corporation - China, World’s II largest producer of XC
|
BRAND |
PRODUCT |
PACKING |
|
Ziboxan |
Xanthan Gum Pharma F80 FDA |
25kg Box |
OTHER PRODUCTS
|
ITEM NAME |
PACKING |
MANUFACTURER |
|
Ichthammol CP 2000 |
20kg Tin |
China |
|
Mannitol Pyrogen Free USP/BP |
25kg Bag |
Bright Moon Seaweed - China |
|
Beta cyclodextrin |
10kg drawing |
|
|
Calcium Dobesilate BP 2002 |
25 Kg Drum |
China |
|
Chloro Promozine HCL – BP 98 |
25 Kg |
China |
|
D-Biotin |
25 Kg |
China |
|
Captopril |
5 Kg |
China |
|
Tretonion |
100 Gms |
China |
|
Piracetam |
25 Kg Drum |
China |
|
Clavulanate Potassium + Avicel |
2 Kg Bag |
Mexico |
|
Benfotiamine |
5 Kg |
Japan |
|
Folic Acid |
20 Kg Drum |
China |
|
Isotretinion |
1 Kg |
China |
|
L-Phenylalanine |
25kg. Drum |
The NutraSweet Co, U.S.A |
|
L – Arginine Base |
25kg. Drum |
Shin Star – China |
|
L – Caritine – L-Tartarate |
25 Kg |
China |
|
N-Acetyl – L-Cysteine USP 24 |
25 Kg Drum |
China |
|
N-Acetyl- L-Acetate |
25 Kg Drum |
China |
|
Methyl
Cobalamine |
Adenosyl
Colamine (Cobamamide) |
|
Ichthammol
CP 2000 |
L-Caritine
L-Tartarate |
|
Mannitol
Pyrogen Free USP/BP |
N-Acety
L-Cysteine USP 24 |
|
Beta
cyclodextrin |
HPMC
Phthalate (HPMC-P55) |
|
Calcium
Dobesilate BP 2002 |
Acesulfame-
K |
|
Chlore
Promozine HCl-BP 2000 |
Furazolidone
BP 2003 |
|
D-Biotin |
L-Ornithine
L-Aspartate |
|
Propranolol
HCl BP 2000 |
Clotrimazole
BP 2000 |
|
Ivermectin |
Alpha
Lipoic Acid |
|
Clavulanate
Potassium + Avicel 1:1 |
L-Cartinine
Base |
|
Clavulanate
Potessium + Amoxicillin 1 :5 |
Insitol
NF 12 |
|
Clavulanate
Potassium + Syloid |
Sucralfate
JP12/USP |
|
Benfotiamine |
L-Phenylalanine |
|
Isotretinion
|
L-Arginine
Base |
|
Sulphaguanidine
BP 2000 |
2-Pyrolidone
(BASF) |
|
Sulphaguanidine
BP 2000 |
Folic
Acid |
|
Tranexamic
Acid |
Vitamin
E |
|
Fructose
|
Meglumine |
We
visited the office of the concern where we observed the following :
·
Name
Board could be seen and the visibility of the Name Board is good.
·
The
concern’s office is easy to locate.
·
Subject
is located in an upmarket area.
·
Subject
is located in between Nyniappa Naicken Street and Mint street opposite Dadha
Pharmaceuticals.
·
Items
such as Telephones, Fax Machines, Computers, Air Conditioner and Office
Equipments could be seen at the concern’s office.
CMT REPORT [Corruption, Money laundering & Terrorism]
The
Public Notice information has been collected from various sources including but
not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION
ON DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.
2] Court
Declaration :
No records exist to suggest that subject is or was the
subject of any formal or informal allegations, prosecutions or other official
proceeding for making any prohibited payments or other improper payments to
government officials for engaging in prohibited transactions or with designated
parties.
3] Asset
Declaration :
No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.
4] Record
on Financial Crime :
Charges or conviction registered
against subject: None
5] Records
on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records
on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal
Records
No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.
8] Affiliation
with Government :
No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.
9] Compensation
Package :
Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on the subject.
CORPORATE
GOVERNANCE
MIRA
INFORM as part of its Due Diligence do provide comments on Corporate Governance
to identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a
company’s management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject
is not known to have contravened any existing local laws, regulations or
policies that prohibit, restrict or otherwise affect the terms and conditions
that could be included in the agreement with the subject.
FOREIGN
EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US
Dollar |
1 |
Rs.44.66 |
|
UK
Pound |
1 |
Rs.77.47 |
|
Euro |
1 |
Rs.53.47 |
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
55 |
This score
serves as a reference to assess SC’s credit risk and to set the amount of
credit to be extended. It is calculated from a composite of weighted scores
obtained from each of the major sections of this report. The assessed factors
and their relative weights (as indicated through %) are as follows:
Financial condition (40%) Ownership background (20%) Payment record (10%)
Credit history (10%) Market trend (10%) Operational
size (10%)
RATING
|
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely
sound financial base with the strongest capability for timely payment of
interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate
working capital. No caution needed for credit transaction. It has above
average (strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial &
operational base are regarded healthy. General unfavourable factors will not
cause fatal effect. Satisfactory capability for payment of interest and
principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is
considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable &
favourable factors carry similar weight in credit consideration. Capability
to overcome financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are
apparent. Repayment of interest and principal sums in default or expected to
be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk
exists. Caution needed to be exercised |
Credit not recommended |